We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Recommends Early, Pre-Approval Trials in Pediatrics for Systemic Dermatitis Drugs
FDA Recommends Early, Pre-Approval Trials in Pediatrics for Systemic Dermatitis Drugs
The FDA published a new draft guidance outlining how early sponsors should incorporate pediatric patients, and the relevant age groups, for systemic therapies for atopic dermatitis.